Your Messages Inbox
Your Article Summary
See Latest ArticlesEuropean Approval for UCB's Cimzia
PharmExec, 06/29/09
Europe's drug watchdog has recommended EU approval of UCB's rheumatoid arthritis treatment Cimzia. UCB said that the drug will be made available in the Europe before the end of the year and is now only awaiting marketing authorisation from the EU. Cimzia belongs to a class of drugs that block an inflammatory protein known as a tumour necrosis factor.
Today in Drug/Product Approvals...keeping you current
Receive free subspecialty "5-minute updates" via email
US FDA approves SEROQUEL for the pediatric treatment of schizophrenia and bipolar mania
AstraZeneca, 12/07/09
US FDA approves SEROQUEL XR for add-on treatment of Major Depressive Disorder
AstraZeneca, 12/07/09
FDA Approves Initiation of Clinical Studies in the U.S. for T2000, Taros Proprietary Non-Sedating Barbiturate Compound
Taro Pharmaceuticals USA, 12/07/09
Article Search
Sponsor